Abbott Laboratories (Pakistan) Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PK0025701019
PKR
994.67
-2.47 (-0.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
19,819.13
19,061.34
17,346.45
18,613.12
17,364.55
16,170.60
16,028.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
19,819.13
19,061.34
17,346.45
18,613.12
17,364.55
16,170.60
16,028.93
Raw Material Cost
13,262.57
12,463.38
11,652.71
13,162.85
11,782.03
12,350.67
11,677.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.66
33.76
3.95
5.03
5.99
5.94
6.66
Selling and Distribution Expenses
3,432.00
3,278.57
3,052.66
2,473.12
2,715.32
2,621.58
2,681.17
Other Expenses
1.42
-0.09
2.38
1.38
2.45
0.71
1.21
Total Expenditure (Excl Depreciation)
16,726.45
15,774.78
14,733.16
15,654.75
14,527.87
14,985.25
14,377.48
Operating Profit (PBDIT) excl Other Income
3092.7
3286.6000000000004
2613.2999999999997
2958.3999999999996
2836.7000000000003
1185.4
1651.5
Other Income
143.12
72.78
205.76
165.93
83.00
198.49
244.38
Operating Profit (PBDIT)
3,866.43
3,776.80
3,179.68
3,443.87
3,305.90
1,714.12
2,295.91
Interest
17.66
33.76
3.95
5.03
5.99
5.94
6.66
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
6,556.56
6,597.96
5,693.74
5,450.27
5,582.52
3,819.94
4,351.37
Depreciation
839.69
492.81
447.44
453.12
448.11
446.09
433.14
Profit Before Tax
3,009.08
3,250.23
2,728.29
2,985.73
2,851.81
1,262.09
1,856.11
Tax
1,186.54
1,306.73
1,128.62
1,700.78
1,042.66
640.71
337.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,822.55
1,943.50
1,599.67
1,284.95
1,809.14
621.38
1,518.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,822.55
1,943.50
1,599.67
1,284.95
1,809.14
621.38
1,518.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,822.55
1,943.50
1,599.67
1,284.95
1,809.14
621.38
1,518.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
28,354.83
26,436.08
24,418.58
23,724.64
22,431.58
20,541.11
19,838.59
Earnings per share (EPS)
18.62
19.85
16.34
13.13
18.48
6.35
15.51
Diluted Earnings per share
18.62
19.85
16.34
13.13
18.48
6.35
15.51
Operating Profit Margin (Excl OI)
14.55%
16.85%
14.56%
15.18%
15.98%
6.61%
10.1%
Gross Profit Margin
19.42%
19.64%
18.31%
18.48%
19.0%
10.56%
14.28%
PAT Margin
9.2%
10.2%
9.22%
6.9%
10.42%
3.84%
9.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 3.98% vs 9.89% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -6.23% vs 21.49% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 0.52% vs 24.55% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -47.63% vs 766.67% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Abbott Laboratories (Pakistan) Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(PKR)
Change(%)
Net Sales
19,819.13
14,188.01
5,631.12
39.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
19,819.13
14,188.01
5,631.12
39.69%
Raw Material Cost
13,262.57
8,974.56
4,288.01
47.78%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.66
0.00
17.66
Selling and Distribution Expenses
3,432.00
1,833.49
1,598.51
87.18%
Other Expenses
1.42
0.00
1.42
Total Expenditure (Excl Depreciation)
16,726.45
10,808.05
5,918.40
54.76%
Operating Profit (PBDIT) excl Other Income
3,092.69
3,379.96
-287.27
-8.50%
Other Income
143.12
-112.84
255.96
226.83%
Operating Profit (PBDIT)
3,866.43
3,644.57
221.86
6.09%
Interest
17.66
0.00
17.66
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
6,556.56
5,213.45
1,343.11
25.76%
Depreciation
839.69
352.77
486.92
138.03%
Profit Before Tax
3,009.08
3,291.80
-282.72
-8.59%
Tax
1,186.54
1,254.51
-67.97
-5.42%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,822.55
2,037.29
-214.74
-10.54%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,822.55
2,037.29
-214.74
-10.54%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,822.55
2,037.29
-214.74
-10.54%
Equity Capital
0
0
0.00
Face Value
10.00
10.00
0.00
Reserves
28,354.83
29,732.17
-1,377.34
-4.63%
Earnings per share (EPS)
18.62
6.40
12.22
190.94%
Diluted Earnings per share
18.62
6.40
12.22
190.94%
Operating Profit Margin (Excl OI)
14.55%
24.00%
0.00
-9.45%
Gross Profit Margin
19.42%
25.69%
0.00
-6.27%
PAT Margin
9.20%
14.36%
0.00
-5.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,981.91 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 3.98% vs 9.89% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 14.14% vs 24.19% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 182.25 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -6.23% vs 21.49% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.74% vs 26,901.49% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 372.33 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.52% vs 24.55% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 15.53% vs 483.86% in Sep 2024

Quarterly - Interest
Interest 1.77 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -47.63% vs 766.67% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 195.00% vs -15.49% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.55%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024